A study has shown how data, collected by wearable technology, can identify disease flare-ups up to seven weeks in advance.
Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...
A new study from Karolinska Institutet explores the connection between inflammatory bowel disease (IBD) and chronic kidney ...
A common antibiotic prescribed for infective diarrhea may also be effective in treating a specific type of inflammatory bowel ...
Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...
Extraintestinal manifestations and arthralgia are significant predictors of IBD-related arthritis among patients with CD, while sacroiliitis was not associated.
Preclinical Data Highlight TP-317’s Anti-Inflammatory, Epithelial Barrier-Protective Effects ...
SAN FRANCISCO — Despite advances in treatment for inflammatory bowel disease, more than 55% of ... purchasing essential items (21.4%). “These findings highlight the need for health care ...
Manipulation of gut flora to enhance its protective and beneficial role represents a promising field of new therapeutic strategies of inflammatory bowel disease. In this review, we discuss the ...
Every case was checked again according to the suggested guidelines for the diagnosis and treatment of inflammatory bowel disease (IBD ... and/or typical biopsy findings; (ii) typical clinical ...
The findings highlight ... inflammation-related diseases. "Therapies aimed at improving mitochondrial activity could benefit inflammatory diseases such as inflammatory bowel disease, sepsis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback